![Daniel Sharp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Sharp
Director/Board Member at
ALCIDION GROUP LIMITED
Net worth: 181 571 $ as of 29/09/2026
Profile
Mr. Daniel Sharp, CFA, is an Independent Non-Executive Director at Alcidion Group Ltd. He is on the Board of Directors at Botanix Pharmaceuticals Ltd. and Alcidion Group Ltd. Mr. Sharp was previously employed as an Independent Non-ExecutiveDirector by ImpediMed Ltd., an Independent Non-Executive Director by Race Oncology Ltd., an Executive Director by Canaccord Genuity (Australia) Ltd., and an Executive Director by Shaw & Partners Corporate Finance Pty Ltd. He received his undergraduate degree from Monash University and a graduate degree from Monash University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/06/2025 | 1,378,572 ( 0.1% ) | 105 502 $ | 29/09/2026 | |
| 16/10/2026 | 6,075,791 ( 0.22% ) | 76 069 $ | 29/09/2026 |
Daniel Sharp active positions
| Companies | Position | Start |
|---|---|---|
| ALCIDION GROUP LIMITED | Director/Board Member | 31/08/2021 |
Former positions of Daniel Sharp
| Companies | Position | End |
|---|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Director/Board Member | 16/10/2026 |
| IMPEDIMED LIMITED | Director/Board Member | 27/09/2023 |
| RACURA ONCOLOGY LTD | Director/Board Member | 28/06/2023 |
Canaccord Genuity (Australia) Ltd.
 Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Director/Board Member | 31/12/2019 |
Shaw & Partners Corporate Finance Pty Ltd.
 Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Education of Daniel Sharp
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Botanix Pharmaceuticals Ltd.
 Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImpediMed Ltd.
 ImpediMed Ltd. Medical SpecialtiesHealth Technology Develops and distributes medical devices for use clinical assessment and monitoring of human disorders and diseases | Health Technology |
Shaw & Partners Corporate Finance Pty Ltd.
Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Alcidion Group Ltd.
 Alcidion Group Ltd. Packaged SoftwareTechnology Services Develops healthcare software | Technology Services |
Canaccord Genuity (Australia) Ltd.
Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
- Stock Market
- Insiders
- Daniel Sharp
